Gallium radiopharmaceutical chemistry

International Journal of Radiation Applications and Instrumentation.

Volumn 16, Issue 5, 1989, Pages

  Green, Mark A ^a   Welch, Michael J ^b  

^a PURDUE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM 67; GALLIUM 68; GALLIUM CITRATE GA 67; GALLIUM COMPOUND; RADIOISOTOPE; TRANSFERRIN GA 68; UNCLASSIFIED DRUG;

ABSCESS; CANCER SCINTISCANNING; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 34347390743     PISSN: 08832897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0883-2897(89)90053-6     Document Type: Review

References (138)

1. A review of radiopharmaceutical development with short-lived generator-produced radionuclides other than Tc-99m
2. Preparation of positron emitting radiopharmaceuticals
3. Special characteristics and potential for dynamic function studies with PET
4. Positron emission tomography
5. Gallium and indium
6. The chemistry of gallium
7. The stereochemistry of some elements of Group III
8. Adducts of gallium, indium, and thallium halides, pseudohalides, and hydrides
9. Other aspects of the chemistry of gallium, indium, and thallium
10. The coordination of indium
11. Hard and soft acids and bases
12. Hard and soft acids and bases
13. Aqueous complexes of gallium(III)
14. Tricatecholamide radiopharmaceuticals
15. New multidentate ligands, 22. N,N′-dipyridoxylethylenediamine-N,N′-diacetic acid: A new chelating ligand for trivalent metal ions
16. Positron tomographic imaging of the liver: Ga-68 iron hydroxide colloid
17. Thermodynamic binding constants for gallium transferrin
18. A method for determining the pH stability range of gallium radiopharmaceuticals
19. Octahedral ditertiary arsine complexes of tervalent gallium and indium
20. Cationic Tc-99m complexes as potential myocardial imaging agents
21. Basal kinetic studies of Tc-99m DMPE as a myocardial imaging agent in the dog
22. The chemistry of gallium and indium as related to radiopharmaceutical production
23. Kinetics of binding of carrier-free Ga-67 to human transferrin
24. Radiogallium localization in tumors: Blood binding and transport and the role of transferrin
25. Human serotransferrin: Structure and function
26. The conformational state of iron proteins
27. Decreased tumor uptake of gallium-67 in animals after whole-body irradiation
28. Role of synergistic ligand binding in the gallium-transferrin complex
29. Effect of binding on the conformation of enterobactin A proton and carbon-13 nuclear magnetic resonance study
30. Ga-68 1,1,1-Tris(5-methoxysalicylaldiminomethylethane): A potential tracer for evaluation of myocardial blood flow by positron emission tomography
31. Synthesis and crystallographic characterization of a gallium salicylaldimine complex of radiopharmaceutical interest
32. The molecular structure of indium oxine
33. An improved gallium-68 cow
34. Location of brain tumors with the positron scintillation camera
35. Gallium-68 as a scanning agent for intracranial lesions
36. Dynamic positron emission tomography for study of cerebral hemodynamics in a cross section of study of the head using positron emitting Ga-68-EDTA and Kr-77
37. A kinetic evaluation of blood-brain permeability in human brain tumors with Ga-68 EDTA and PET
38. Measurement of blood-brain barrier permeability with positron emission tomography and Ga-68 EDTA
39. 68Ga)EDTA in supratentorial tumors
40. A gallium-68 positron cow for medical use
41. Bone scanning with gallium-68: a carrier effect
42. Chemistry of Ga-68 EDTA complex
43. Kinetics of radionuclides used for bone studies
44. Rapid separation of generator-produced gallium-68 from EDTA eluate
45. Investigation of Ga-68-Tripolyphosphate as a potential bone-scanning agent
46. A method for the preparation and quality control of gallium-68 radiopharmaceuticals
47. Long term study of high level Ge-68 generators
48. A new Ge-68/Ga-68 radioisotope generator system
49. A new germanium-68/gallium-68 generator
50. Gallium-68 labeled red cells and platelets: New agents for positron tomography
51. The design and testing of an automated Ge-68/Ga-68 solvent extraction generator
52. Development of a chromatographic Ge-68/Ga-68 generator yielding ionic gallium
53. Potential column chromatography for ionic Ga-68 II: Organic ion exchangers as chromatographic supports
54. Development of an ionic Ge-68/Ga-68 generator III: Chelate resins as chromatographic substrates for germanium
55. 68Ga in dilute HCl
56. A generator of gallium-68 based on zirconium hydroxide
57. A new generator for ionic gallium-68
58. Germanium-68/gallium-68 generator for the one step elution of ionic gallium-68
59. 68Ga generator with alpha-ferric oxide support
60. Comparison of Ge-68/Ga-68 generator systems for radiopharmaceutical production
61. Comparison of germanium-68/gallium-68 generator systems for radiopharmaceutical production
62. Gallium-68 lipophilic complexes for labeling platelets
63. The radionuclide identification of tumors
64. Tumor imaging radiopharmaceuticals
65. The medical use of gallium radionuclides: a brief history with some comments
66. Mechanisms of localization of gallium-67 in tumors
67. Gallium-67 imaging in the management of Hodgkin's disease and other malignant lymphomas
68. Role of gallium-67 in inflammatory disease
69. The use of gallium-67 in pulmonary disorders
70. Gallium-67 imaging in abdominal disease
71. Mechanism of gallium-67 accumulation in inflammatory lesions
72. Bone scanning with gallium-68: a carrier effect
73. Gallium-68 citrate: A clinically useful skeletal scanning agent
74. 68Ga
75. 68Ga compound for liver scanning
76. Liver and kidney imaging with Ga-68-Labeled Dihydroxyanthraquinones
77. 68Ga labeled proteins
78. A comparison of positron-emitting blood pool imaging agents
79. Measurements of pulmonary vascular permeability with PET and gallium-68 transferrin
80. Regional lung water and hematocrit determined by position emission tomography
81. Gallium-68 labeling of albumin and albumin microspheres
82. Albumin microspheres labeled with Ga-67 by chelation
83. Labeling of tin-soaked albumin microspheres with Ga-68
84. Simple fast preparation of gallium-68 labeled human serum albumin microspheres
85. Stable labeling of serum albumin microspheres with gallium-68
86. 2 inhalation methods
87. Quantification of regional myocardial blood flow in vivo with 0–15 water
88. Quantitative measurement of regional pulmonary blood flow with positron emission tomography
89. Synthesis and biodistribution of a series of lipophilic gallium-67 Tris(salicylaldimine) complexes
90. Evaluation of PLED as a chelating ligand for the preparation of gallium and indium radiopharmaceuticals
91. Targeting radiopharmaceuticals: comparative biodistribution studies of gallium and indium complexes of multidentate ligands
92. 68Ga-EDTA in rats
93. 68Ga compound for kidney scanning
94. A Ga-68 labeled tetrabromophthalein (Ga-68 BP-IDA) for positron imaging of hepatobiliary function
95. Lipophilic enterobactin analogues. Stabilities of the gallium and ferric ion complexes of terminally N-sub-stituted catecholamides
96. Phenolic amino-carboxylic acids as gallium-binding radiopharmaceuticals
97. New Ga-68-labeled skeletal-imaging agents for positron scintigraphy
98. Investigation of Ga-68-tripolyphosphate as a potential bone-scanning agent
99. Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies
100. Radioactive labeling of antibody: A simple and efficient method
101. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice
102. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA
103. Studies on high specific activity labeling of proteins using bifunctional chelates: Ga-67-DF-HSA
104. Labeling studies of proteins using bifunctional chelates: The desferrioxamine-human serum albumin (DF-HSA) conjugate
105. Radiolabeled compounds in biomedical interest containing radioisotopes of gallium and indium
106. Gallium mechanisms
107. The mechanism of tumor localization of gallium: an update and reassessment
108. The synthesis, thermodynamic behavior and biological properties of metal-ion-specific sequestering agents for iron and the actinides
109. Use of tricatecholamine ligands to alter the biodistribution of gallium-67
110. 3+ citrate complexes
111. Iron(III)-nitrilo-triacetate: an agent for reducing the time interval of tumor imaging with gallium citrate
112. Factors affecting the cerebral uptake of gallium complexes
113. Reassessment of the use of desferrioxamine B in iron overload
114. Relative stability of In-111 and Ga-67 desferrioxamine and human transferrin complexes
115. Pharmacologic enhancement of gallium-67 tumor-to-blood ratios for EMT-6 Sarcoma (BALB/c mice)
116. Effects of desferrioxamine on Ga-67 distributions in tumor bearing mice
117. Deferoxamine mesylate enhancement of Ga-67 tumor-to-blood ratios and tumor imaging
118. The effects of deferoxamine mesylate on gallium-67 distribution in normal and abscess-bearing animals
119. Desferoxamine mesylate (Desferal): a contrast enhancing agent for gallium-67 imaging
120. Measurement of flow in perfused organs using microsphere techniques
121. Albumin microspheres: current methods of preparation and use
122. Radiolabeling of platelets
123. Labeling mechanism and localization of indium-111 in human platelets
124. Indium-111 labeled cellular blood components: Mechanisms of labeling and intracellular location in human neutrophils
125. Mechanism of ionophoric transport of indium-111 cations through a lipid bilayer
126. 14C and tris-8-quinolinolato complexes of tervalent typical elements
127. Bifunctional chelating agents: linking radiometals to biological molecules
128. Metal chelates as probes of biological systems